The US FDA has granted Kite’s Yescarta (axicabtagene ciloleucel) a Regenerative Medicine Advanced Therapy (RMAT) designation ...

AstraZeneca and Daiichi Sankyo's Dato-DXd failed to improve survival in a breast cancer study. Gilead Sciences' Kite will bow ...

Kite foiling sees riders ‘fly’ above the water on hydrofoils attached to boards and powered by huge kites. They can reach incredible speeds of up to 45 knots (51mph). Here's everything you need to ...

Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy designed to ...

Shanghai Fosun Pharma announced plans to buy out its JV partner, Kite Pharma, gaining full control of the JV’s two CAR-T products in China. Organon China, a women’s health company, acquired ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture with Fosun Pharma.

Zerodha founder and CEO Nithin Kamath announced on Tuesday, September 17, that 'Alert Trigger Orders (ATO)' will soon be available on trading and investment platform Kite mobile. Zerodha has ...

Christi Shaw, who ran Kite for several years but left the company in 2023, has joined Kyverna’s board as part of the leadership change. “Kyverna today sits on the precipice of its next chapter, as KYV ...

The new CEO — formerly of Kite Pharma and Genentech — will receive an annual salary of $625,000 plus a one-time bonus of $650,000. Peter Maag, who led cell therapy company Kyverna Therapeutics ...

Kyver­na Ther­a­peu­tics has re­shaped its C-suite just sev­en months af­ter se­cur­ing one of the splashiest biotech IPOs in re­cent years as it rode the waves … ...

Most recently, he served as Senior Vice President, Global Head of Commercial at Kite Pharma (a Gilead Company). In this role, Mr. Biddle led multiple product launches and market-building ...